Comparative induction of CYP3A and CYP2B in rat liver by 3-benzoylpyridine and metyrapone

Chemico-Biological Interactions

Volumn 113, Issue 3, 1998, Pages 161-173

  Murray, Michael ^a   Sefton, Rachel M ^a   Martini, Robert ^a   Butler, Alison M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

3 Benzoylpyridine; Cytochrome P450; Gene regulation; Metyrapone

Indexed keywords

ANDROSTENEDIONE; CYTOCHROME P450; DEXAMETHASONE; ISOENZYME; METYRAPONE; PYRIDINE DERIVATIVE; TROLEANDOMYCIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG OXIDATION; ENZYME INDUCTION; GENE CONTROL; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANDROSTENEDIONE; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; HYDROXYLATION; LIVER; MALE; METYRAPONE; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; PYRIDINES; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0031779444     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00017-9     Document Type: Article

References (43)

1. Hecht S.S., Trushin N., Castonguay A., Rivenson A. Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res. 46:1986;498-502.
2. Hecht S.S., Trushin N. DNA and hemoglobin alkylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its major metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis. 9:1988;1665-1668.
3. Kim S.G., Philpot R.M., Novak R.F. Pyridine effects on P450IIE1, IIB and IVB expression in rabbit liver: Characterization of high- and low-affinity pyridine N-oxygenases. J. Pharmacol. Exp. Ther. 259:1991;470-477.
4. Kim S.G., Reddy S.L., States J.C., Novak R.F. Pyridine effects on the expression and molecular regulation of the cytochrome P450 1A gene subfamily. Mol. Pharmacol. 40:1991;52-57.
5. Kim H., Putt D., Reddy S., Hollenberg P.F., Novak R.F. Enhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: Differential induction kinetics and molecular basis of expression. J. Pharmacol. Exp. Ther. 267:1993;927-936.
6. Franklin M.R. Drug metabolizing enzyme induction by simple diaryl pyridines: 2-Substituted isomers selectively increase only conjugation enzyme activities, 4-substituted isomers also induce cytochrome P450. Toxicol. Appl. Pharmacol. 111:1991;24-32.
7. Kobayashi Y., Matsuura Y., Kotani E., Iio T., Fukuda T., Aoyagi T., Tobinaga S., Yoshida T., Kuroiwa Y. Induction of hepatic microsomal cytochrome P450 and drug-metabolizing enzymes by 4-benzylpyridine and its structurally related compounds in rats: Dose- and sex-related differential induction of cytochrome P450 species. Biochem. Pharmacol. 43:1992;2151-2159.
8. Kobayashi Y., Matsuura Y., Kotani E., Fukuda T., Aoyagi T., Tobinaga S., Yoshida T., Kuroiwa Y. Structural requirements for the induction of hepatic microsomal cytochrome P450 by imidazole- and pyridine-containing compounds in rats. J. Biochem. 114:1993;697-701.
9. Yoshida T., Kobayashi Y., Masuko T., Hashimoto Y., Kuroiwa Y. Differential effects of 3 dipyridyl isomers on hepatic microsomal cytochrome P450 and heme oxygenase in rats. Toxicol. Lett. 76:1995;145-153.
10. Shean K., Paine A.J. Immunochemical quantification of cytochrome P-450 IA and IIB subfamilies in the livers of metyrapone-treated rats: Relevance to the ability of metyrapone to prevent the loss of cytochrome P-450 in rat hepatocyte culture. Biochem. J. 267:1990;715-719.
11. Wright M.C., Paine A.J., Skett P., Auld R. Induction of rat hepatic glucocorticoid-inducible cytochrome P450 3A by metyrapone. J. Steroid Biochem. Mol. Biol. 48:1994;271-276.
12. Wright M.C., Wang X.-J., Pimenta M., Ribeiro V., Paine A.J., Lechner M.C. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid. Mol. Pharmacol. 50:1996;856-863.
13. Kirsch D.M., Weger N. Effect of the bispyridinium compounds HGG-12, HGG-42, and obidoxime on synaptic transmission and NAD(P)H-fluorescence in the superior cervical ganglion of the rat in vitro. Arch. Toxicol. 47:1981;217-232.
14. Born J.L., Hadley W.M. Inhibition of in vitro cytochrome P-450-catalyzed reactions by substituted pyridines. J. Pharm. Sci. 69:1980;465-466.
15. Kirata S., Matsubara T. cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats. Arch. Biochem. Biophys. 307:1993;253-258.
16. Komori M., Oda Y. A major glucocorticoid-inducible P450 in rat liver is not P450 3A1. J. Biochem. 116:1994;114-120.
17. Gonzalez F.J., Song B.-J., Hardwick J.P. Pregnenolone 16alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Mol. Cell. Biol. 6:1986;2969-2976.
18. Chan Y.-L., Gutell R., Noller H.F., Wool I.G. The nucleotide sequence of a rat ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18S ribosomal ribonucleic acid. J. Biol. Chem. 259:1984;224-230.
19. Martini R., Murray M. Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation. Arch. Biochem. Biophys. 303:1993;57-66.
20. Murray M., Wilkinson C.F., Dube C.E. Effects of dihydrosafrole on cytochromes P-450 and drug oxidation in hepatic microsomes from control and induced rats. Toxicol. Appl. Pharmacol. 68:1983;66-76.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
22. Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239:1964;2370-2378.
23. Jiang X.-M., Cantrill E., Farrell G.C., Murray M. Pretranslational down-regulation of male specific hepatic P450s after portal bypass. Biochem. Pharmacol. 48:1994;701-708.
24. Waxman D.J., Ko A., Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J. Biol. Chem. 258:1983;11937-11947.
25. Prough R.A., Burke M.D., Mayer R.T. Direct fluorometric methods for measuring mixed-function oxidase activity. Methods Enzymol. 52:1978;372-377.
26. UT-A, in rats with portal bypass. Relevance to estradiol accumulation and impaired drug metabolism in hepatic cirrhosis. J. Clin. Invest. 83:1989;1211-1216.
27. Murray M., Hudson A.M., Yassa V. Hepatic microsomal metabolism of the anthelmintic benzimidazole fenbendazole: Enhanced inhibition of cytochrome P450 reactions by oxidized metabolites of the drug. Chem. Res. Toxicol. 5:1992;60-66.
28. J. Sambrook, E.F. Fritsch, T. Maniatis, in: Molecular cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989, pp. 7.19-7.22.
29. Waxman D.J., Lapenson D.P., Nagata K., Conlon H.D. Participation of two structurally related enzymes in rat hepatic microsomal androstenedione 7α-hydroxylation. Biochem. J. 265:1990;187-194.
30. Franklin M.R. Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compounds. Methods Enzymol. 206:1991;559-573.
31. Mahnke A., Strotkamp D., Roos P.H., Hanstein W.G., Chabot G.G., Nef P. Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch. Biochem. Biophys. 337:1997;62-68.
32. Kim S.G., Shehin S.E., States J.C., Novak R.F. Evidence for increased translational efficiency in the induction of P450 IIE1 by solvents: Analysis of P450 IIE1 mRNA polyribosomal distribution. Biochem. Biophys. Res. Commun. 172:1990;767-774.
33. J.P. Whitlock, M.S. Denison, Induction of cytochrome P450 enzymes that metabolize xenobiotics, in: P.R. Ortiz de Montellano (Ed.), Cytochrome P450: Structure, Mechanism and Biochemistry, 2nd ed., Plenum Press, New York, 1995, pp. 367-390.
34. Wright M.C., Paine A.J. Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein. Biochem. Biophys. Res. Commun. 201:1994;973-979.
35. Quattrochi L.C., Mills A.S., Barwick J.L., Yockey C.B., Guzelian P.S. A novel cis-acting element in a liver cytochrome P450 3A gene confers synergistic induction by glucocorticoids and antiglucocorticoids. J. Biol. Chem. 270:1995;28917-28923.
36. Huss J.M., Wang S.I., Astrom A., McQuiddy P., Kasper C.B. Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif. Proc. Natl. Acad. Sci. USA. 93:1996;4666-4670.
37. Kocarek T.A., Schuetz E.G., Guzelian P.S. Regulation of phenobarbital-inducible cytochrome P450 2B1/2 mRNA by lovastatin and oxysterols in primary cultures of adult rat hepatocytes. Toxicol. Appl. Pharmacol. 120:1993;298-307.
38. Williams J.A., Chenery R.J., Berkhout T.A., Hawksworth G.M. Induction of cytochrome P4503A by the antiglucocorticoid mifepristone and a novel hypocholesterolemic drug. Drug Metab. Dispos. 25:1997;757-761.
39. Hansch C., Leo A., Unger S.H., Kim H.K., Nikaitani D., Lien E.J. Aromatic substituent constants for structure-activity correlations. J. Med. Chem. 16:1973;1207-1216.
40. Murray M., Wilkinson C.F. Interactions of nitrogen heterocycles with cytochrome P-450 and monooxygenase activity. Chem.-Biol. Interact. 50:1984;267-275.
41. Murray M., Reidy G.F. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 42:1990;85-101.
42. Tanouchi T., Kawamura M., Ohyama I., Kajiwara I., Iguchi Y., Okada T., Miyamoto T., Taniguchi K., Hayashi M., Iizuka K., Nakazawa M. Highly selective inhibitors of thromboxane synthetase. 2. Pyridine derivatives. J. Med. Chem. 24:1981;1149-1155.
43. 2 biosynthesis. J. Biol. Chem. 264:1989;141-150.